Literature DB >> 2413022

Plasminogen and tissue-type plasminogen activator bind to immobilized fibronectin.

E M Salonen, O Saksela, T Vartio, A Vaheri, L S Nielsen, J Zeuthen.   

Abstract

Fibronectin immobilized onto polystyrene surface was found to bind plasminogen and tissue-type plasminogen activator (t-PA) but only slightly the urokinase type as determined using mono- and polyclonal antibodies against the activators. Of the defined fibronectin fragments tested, the Mr 120,000-140,000 fragment was found to bind both plasminogen and t-PA. Proteolytically modified plasminogen (Lys-plasminogen) bound considerably better than the native form (Glu-plasminogen). Experiments with 125I-plasminogen yielded Kd = 9.1 X 10(-8) M for the binding to immobilized fibronectin. The partially or completely inactive single-chain form of t-PA (pro-t-PA) bound considerably better than the activated two-chain form. Lysine at greater than 3 mM inhibited the binding of plasminogen. The interaction was independent of calcium ions. CaCl2 (greater than 0.5 mM) and NaCl (greater than 0.2 M) inhibited the binding of pro-t-PA and of t-PA. Fibronectin-bound t-PA retained its ability to activate plasminogen. The observed interactions may operate in directional proteolysis localizing plasminogen and plasminogen activator to degrade fibronectin-containing extracellular matrix including fibrin clots.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2413022

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  Regulation of proteinases during mouse peri-implantation development: urokinase-type plasminogen activator expression and cross talk with matrix metalloproteinase 9.

Authors:  M G Martínez-Hernández; L A Baiza-Gutman; A Castillo-Trápala; D Randall Armant
Journal:  Reproduction       Date:  2010-11-12       Impact factor: 3.906

2.  Binding of human plasminogen to basement-membrane (type IV) collagen.

Authors:  M S Stack; T L Moser; S V Pizzo
Journal:  Biochem J       Date:  1992-05-15       Impact factor: 3.857

3.  Expression and characterization of wild-type TFPI and the [P151L]TFPI mutant in insect cells.

Authors:  Elmar Thyzel; Sabine Siegling; Thomas Brinkmann; Knut Kleesiek; Christian Götting
Journal:  Mol Cell Biochem       Date:  2006-02       Impact factor: 3.396

4.  Culture of retinal pigment epithelial cells from subretinal fluid.

Authors:  V Sirén; E M Salonen; A Vaheri; P Tommila; I Immonen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

5.  Proteolytic disruption of laminin-integrin complexes on muscle cells during synapse formation.

Authors:  M J Anderson; Z Q Shi; S L Zackson
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

Review 6.  Binding of plasminogen activators to fibrin: characterization and pharmacological consequences.

Authors:  R Fears
Journal:  Biochem J       Date:  1989-07-15       Impact factor: 3.857

7.  Modulatory effects of fibronectin on calcium oxalate crystallization, growth, aggregation, adhesion on renal tubular cells, and invasion through extracellular matrix.

Authors:  Supaporn Khamchun; Kanyarat Sueksakit; Sakdithep Chaiyarit; Visith Thongboonkerd
Journal:  J Biol Inorg Chem       Date:  2019-01-30       Impact factor: 3.358

8.  Lp(a)/apo(a) modulate MMP-9 activation and neutrophil cytokines in vivo in inflammation to regulate leukocyte recruitment.

Authors:  Menggui Huang; Yanqing Gong; Jessica Grondolsky; Jane Hoover-Plow
Journal:  Am J Pathol       Date:  2014-03-17       Impact factor: 4.307

9.  Functional heterogeneity of type 1 fimbriae of Escherichia coli.

Authors:  E V Sokurenko; H S Courtney; S N Abraham; P Klemm; D L Hasty
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

10.  LRP1 regulates remodeling of the extracellular matrix by fibroblasts.

Authors:  Alban Gaultier; Margaret Hollister; Irene Reynolds; En-hui Hsieh; Steven L Gonias
Journal:  Matrix Biol       Date:  2009-08-20       Impact factor: 11.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.